
Beach Tree Labs: Innovating biotech solutions for diverse medical conditions and surgical procedures.
Founded with a mission to address unmet medical needs, Beech Tree Labs focuses on the discovery and early-stage development of bioregulatory innovations. The company offers a range of pharmaceutical formulations targeting viral infections like COVID-19 and Herpes, central nervous system diseases such as ALS and Parkinson's, and conditions involving inflammation and fibrosis. Their market focus includes both chronic and acute medical conditions, aiming to improve the quality of life for millions globally.
Beech Tree Labs has attracted notable investors and affiliated experts in the biotechnology field, contributing to its innovative edge. Key achievements include significant advancements in therapies for idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. The company's impact is marked by its commitment to pioneering treatments for complex medical conditions, thereby positioning itself as a leader in bioregulatory innovation.

BioHealthonomics

Bien-Etre Labs

Brii Biosciences
briibio.com

PineTree Therapeutics
pinetreetx.com

Birch Tree Medical

Be Biopharma

BiotechInnova
biotechinnova.com

Incube Labs
incubelabs.com

Regennova
regennova.com

Emerald Health Pharmaceuticals

Bluejay Therapeutics
bluejaytx.com

Treeline Biosciences

Pulmatrix
pulmatrix.com

Alveolus Bio
alveolusbio.com

Zymeron
zymeron.com
Companies similar to Beech Tree Labs include BioHealthonomics, Bien-Etre Labs, Brii Biosciences and PineTree Therapeutics.
Beech Tree Labs was founded in 2005.
Beech Tree Labs' headquarters is located in Providence, RI, US.
Beech Tree Labs' most recent funding round was for $7M (USD) in December 2010.
As of Dec 9, 2010, Beech Tree Labs has raised a total of $8.5M (USD).
Beech Tree Labs has 5 employees as of Feb 4, 2024.